International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.13911145
Original Research Article
Neonatal Intestinal Obstruction: A Study of Clinico-Demographic Profiles and Outcomes
Published
Oct. 10, 2024
Abstract

Background: Neonatal intestinal obstruction is a common surgical emergency associated with significant morbidity and mortality. Prompt diagnosis and appropriate intervention are essential to improve survival outcomes. Aim: To evaluate the clinicodemographic profile and outcomes of neonatal intestinal obstruction in a tertiary care setting. Methods: This prospective study included 32 neonates who presented with symptoms of intestinal obstruction and underwent surgical intervention from January 2019 to September 2023. Data on clinical presentation, surgical treatment, and outcomes were collected and analyzed. Results: Of the 32 neonates, 20 (62.5%) were male, and 12 (37.5%) were female. The most common cause of intestinal obstruction was intestinal atresia (10 cases, 31.25%), followed by malrotation (7 cases, 21.8%). The most frequent symptoms were vomiting (seen in 17 cases, 53.1%), failure to pass stool (14 cases, 43.75%), and abdominal distension (10 cases, 31.25%). A total of 25 neonates (78.13%) were successfully discharged, while the mortality rate was 21.87% (7 cases). Conclusion: Intestinal atresia is the leading cause of neonatal intestinal obstruction in this study. Early diagnosis and multidisciplinary management can significantly improve outcomes

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
1397 Views
215 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved